Exon 19 Deletions - Cancer Science

Relevant Publications

Prevalence of EGFR Mutations in Patients With Resected Stage I-III NSCLC: Results From the EARLY-EGFR Study.

Issue Release: 2024

A case of response to combination treatment with TSA-DC-CTL immunotherapy and osimertinib in EGFR mutated advanced lung adenocarcinoma.

Issue Release: 2024

Stage I and II nonsmall cell lung cancer treatment options.

Issue Release: 2024

Splice site and mutations can cause mixed dominant negative/gain of function -associated immune dysregulation with cold urticaria (CU-PLAID).

Issue Release: 2024

Combination of microwave ablation and systemic treatments achieve a long survival time for a patient with metachronous advanced double primary lung and colon adenocarcinoma: A case report.

Issue Release: 2024

Splice site and de novo variants can cause PLCG2-associated immune dysregulation with cold urticaria (PLAID-CU).

Issue Release: 2024

Discovery of a Novel Mutant-Selective Epidermal Growth Factor Receptor Inhibitor Using an Enabled Drug Discovery Platform.

Issue Release: 2024

Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitors.

Issue Release: 2024

NR3C2 microdeletions-an underrecognized cause of pseudohypoaldosteronism type 1A: a case report and literature review.

Issue Release: 2024

Epidermal growth factor receptor-mutated lung carcinomas with insufficient response to epidermal growth factor receptor inhibitors.

Issue Release: 2024

Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in Non-Small Cell Lung Cancer.

Issue Release: 2024

EGFR exon 18 delE709_T710insD mutated stage IV non-small cell lung cancer treated with osimertinib: a case report.

Issue Release: 2024

Case report: fusion mutation combined with amplification responds to EGFR-TKI therapy.

Issue Release: 2024

Current management of uncommon EGFR mutations in non-small cell lung cancer.

Issue Release: 2024

Activity of afatinib in patients with NSCLC harboring novel uncommon mutations with or without co-mutations: a case report.

Issue Release: 2024

Molecular analysis of genetic mutations in non-small cell lung cancer in Morocco.

Issue Release: 2024

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitor for lung adenosquamous cell carcinoma harboring EGFR mutation: a retrospective study and pooled analysis.

Issue Release: 2024

Cost-effectiveness analysis of osimertinib plus chemotherapy for patients with EGFR-mutated advanced non-small cell lung cancer.

Issue Release: 2024

Molecular Testing for Mutation in Moroccan NSCLC Patients: CHU Hassan II-Fez Experience.

Issue Release: 2024

A novel splice-altering TNC variant (c.5247A > T, p.Gly1749Gly) in an Chinese family with autosomal dominant non-syndromic hearing loss.

Issue Release: 2024

Can Hepatic Dysfunction Be Prevented?

How is EtO Sterilization Relevant to Cancer Treatment?

Can Cancer-Arising Tissues Regenerate?

How do telemedicine and digital health tools help?

What Increases Stroke Risk in Cancer Patients?

What Types of Cancer Treatments Typically Require Pre-Authorization?

What are the Challenges in MRD Detection?

Can the N:C Ratio Vary Among Different Types of Cancer?

What are the Treatment Options for KSHV-Associated Diseases?

What to Expect During Therapy Sessions?

Exon 19 Deletions - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics